Technical Analysis for AMRN - Amarin Corporation plc

Grade Last Price % Change Price Change
grade D 18.08 -4.34% -0.82
AMRN closed down 4.34 percent on Friday, July 19, 2019, on 3.57 times normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical AMRN trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Volume Surge Other 0.00%
Calm After Storm Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 20 DMA Bearish -4.34%

Older signals for AMRN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids. The company lead product comprises Vascepa, a prescription-only omega-3 fatty acid comprising icosapent ethyl as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It also engages in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland.
Biopharmaceutical Organic Compounds Nutrition Cardiovascular Diseases Cholesterol Low Density Lipoprotein Lipids Hypertriglyceridemia Saturated Fat
Is AMRN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 23.91
52 Week Low 2.35
Average Volume 7,967,778
200-Day Moving Average 18.4369
50-Day Moving Average 18.9542
20-Day Moving Average 20.648
10-Day Moving Average 21.333
Average True Range 1.0356
ADX 25.85
+DI 21.4965
-DI 35.0242
Chandelier Exit (Long, 3 ATRs ) 20.8032
Chandelier Exit (Short, 3 ATRs ) 20.9568
Upper Bollinger Band 24.3519
Lower Bollinger Band 16.9441
Percent B (%b) 0.15
BandWidth 35.876598
MACD Line 0.3491
MACD Signal Line 0.7908
MACD Histogram -0.4417
Fundamentals Value
Market Cap 4.9 Billion
Num Shares 271 Million
EPS -0.31
Price-to-Earnings (P/E) Ratio -58.32
Price-to-Sales 5.87
Price-to-Book 0.00
PEG Ratio -1.74
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.40
Resistance 3 (R3) 19.50 19.17 19.18
Resistance 2 (R2) 19.17 18.83 19.12 19.11
Resistance 1 (R1) 18.62 18.62 18.46 18.52 19.03
Pivot Point 18.29 18.29 18.20 18.24 18.29
Support 1 (S1) 17.74 17.95 17.58 17.64 17.13
Support 2 (S2) 17.41 17.74 17.36 17.05
Support 3 (S3) 16.86 17.41 16.98
Support 4 (S4) 16.76